Back to Trades
Total Value
$78.7K
Net $78.7K sold
Filing Date
Apr 14, 2026
3 transactions
Sales
$78.7K
3 transactions
Trade Summary
On Apr 10, 2026 through Apr 13, 2026, Camblong Jurgi, Chief Executive Officer, Director, sold $78.7K of SOPHiA GENETICS SA (SOPH) across 3 transactions. The filing covers Ordinary Shares and reflects net selling of $78.7K. Reported prices ranged from $4.72 to $4.76. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- SOPHiA GENETICS SA
- Ticker Symbol
- SOPH
- CIK
- 0001840706
Insider Information
- Name
- Camblong Jurgi
- Role
- Chief Executive Officer, Director
Filing Details
- Filing Date
- Apr 14, 2026
- Transaction Date
- Apr 10, 2026
- Accession Number
- 0001840706-26-000150
- Form Type
- 4
- Net Trading Amount
- -$78.7K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 10, 2026 | Ordinary Shares | 8,500 | $4.72 | Sale | $40.1K |
| Apr 10, 2026 | Ordinary Shares | 3,732 | $4.72 | Sale | $17.6K |
| Apr 13, 2026 | Ordinary Shares | 4,399 | $4.76 | Sale | $21.0K |
Want live alerts when Camblong Jurgi trades again?
Download Insider Trades to track SOPH, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
- (F2)The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.60 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F3)Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- (F4)The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.64 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.